Q4 2023 Agile Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to the Agile Therapeutics Fourth Quarter and Full Year 2023 financial results conference call. Please note, today's event is being recorded I would now like to turn the conference over to Matt Reilly, Head of Investor Relations. Please go ahead.
Hello, everyone, and welcome to today's conference call to discuss our fourth quarter and full year 2023 financial results and corporate update.
Before we start, let me remind you that today's call will include forward-looking statements based on our current expectations, including statements concerning our financial outlook and financing prospects for the future, management's expectations for our future financial and operational performance, including our expectations regarding the market growth of Twirla and our ability to become cash flow positive, our operating expenses, our business strategy, our partnership with faxes and its ability to promote growth, our product supply agreement with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |